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Abstract: OBJECTIVES Non-Cartesian spiral magnetic resonance (MR) acquisition may enable higher
scan speeds, as the spiral traverses the k-space more efficiently per given time than in Cartesian trajecto-
ries. Spiral MR imaging can be implemented in time-of-flight (TOF) MR angiography (MRA) sequences.
In this study, we tested the performance of five 3-dimensional TOF MRA sequences for intracranial vessel
imaging at 1.5 T with qualitative and quantitative image quality metrics based on in vitro and in vivo
measurements. Specifically, 3 novel spiral TOF MRA sequences (spiral-TOFs) and a compressed sensing
(CS) technology-accelerated TOF MRA sequence (CS 3.5) were compared with a conventional (criterion
standard) parallel imaging-accelerated TOF MRA sequence (SENSE). MATERIALS AND METHODS
The SENSE sequence (5:08 minutes) was compared with the CS 3.5 sequence (3:06 minutes) and a
spiral-TOF (spiral, 1:32 minutes), all with identical resolutions. In addition, 2 further isotropic spiral-
TOFs (spiral 0.8, 2:12 minutes; spiral 0.6, 5:22 minutes) with higher resolution were compared with the
SENSE. First, vessel tracking experiments were performed in vitro with a dedicated vascular phantom
to determine possible differences in the depiction of cross-sectional areas of vessel segments. For the
in vitro tests, an additional 3-dimensional proton density-weighted sequence was added for comparison
reasons. Second, 3 readers blinded to sequence details assessed qualitative (16 features) and 2 readers
assessed quantitative (contrast-to-noise ratio [CNR], contrast ratio [CR], vessel sharpness, and full width
at half maximum edge criterion measurements) image quality based on images acquired from scanning
10 healthy volunteers with all 5 TOF sequences. Scores from quantitative image quality analysis were
compared with Kruskal-Wallis, analysis of variance, or Welch’s analysis of variance, followed by Dun-
nett’s or Dunnett’s T3 post hoc tests. Scores from qualitative image quality analysis were compared with
exact binomial tests, and the level of interreader agreement was determined with Krippendorff’s alpha.
RESULTS Concerning the in vitro tests, there were no significant differences between the 5 TOFs and
the proton density-weighted sequence in measuring cross-sectional areas of vessel segments (P = 0.904).
As for the in vivo tests, the CS 3.5 exhibited equal qualitative image quality as the SENSE, whereas
the 3 spiral-TOFs outperformed the SENSE in several categories (P values from 0.002 to 0.031). Specif-
ically, the spiral 0.8 and 0.6 sequences achieved significantly higher scores in 12 categories. Interreader
agreement ranged from poor (alpha = -0.013, visualization of internal carotid artery segment C7) to
substantial (alpha = 0.737, number of vessels visible, sagittal). As for the quantitative metrics, the CS
3.5 and all 3 spiral-TOFs presented with significantly worse CNR than the SENSE ([mean ± SD] SENSE
37.48 ± 7.13 vs CS 3.5 31.14 ± 5.97 vs spiral 19.77 ± 1.65 vs spiral 0.8 16.18 ± 2.14 vs spiral 0.6 10.37
± 1.05). The CR values did not differ significantly between the SENSE and the other TOFs except for
the spiral sequence that showed significantly improved CR (SENSE 0.53 ± 0.03 vs spiral 0.56 ± 0.03).
As for vessel sharpness, the SENSE was outperformed by all spiral-TOFs (SENSE 0.37 ± 0.03 vs spiral
0.52 ± 0.07 vs spiral 0.8 0.53 ± 0.08 vs spiral 0.6 0.73 ± 0.09), whereas the CS 3.5 performed equally
well (SENSE 0.37 ± 0.03 vs CS 3.5 0.37 ± 0.03). Full width at half maximum values did not differ sig-
nificantly between any TOF. CONCLUSIONS Spiral-TOFs may deliver high-quality intracranial vessel
imaging thus matching the performance of conventional parallel imaging-accelerated TOFs (such as the
SENSE). Specifically, imaging can be performed at unprecedented scan times as short as 1:32 minutes
per sequence (70.12% scan time reduction compared with SENSE). Optionally, spiral imaging may also
be used to increase spatial resolution while maintaining the scan time of a Cartesian-based acquisition
schema. The CNR was decreased in spiral-TOF images.
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Objectives: Non-Cartesian spiral magnetic resonance (MR) acquisition may en-
able higher scan speeds, as the spiral traverses the k-space more efficiently per
given time than in Cartesian trajectories. Spiral MR imaging can be implemented
in time-of-flight (TOF)MR angiography (MRA) sequences. In this study, we tested
the performance of five 3-dimensional TOFMRA sequences for intracranial vessel
imaging at 1.5 Twith qualitative and quantitative image quality metrics based on in
vitro and in vivo measurements. Specifically, 3 novel spiral TOF MRA sequences
(spiral-TOFs) and a compressed sensing (CS) technology–accelerated TOF MRA
sequence (CS 3.5) were compared with a conventional (criterion standard) parallel
imaging–accelerated TOF MRA sequence (SENSE).
Materials and Methods: The SENSE sequence (5:08 minutes) was compared
with the CS 3.5 sequence (3:06 minutes) and a spiral-TOF (spiral, 1:32 minutes),
all with identical resolutions. In addition, 2 further isotropic spiral-TOFs (spiral
0.8, 2:12minutes; spiral 0.6, 5:22minutes) with higher resolutionwere compared
with the SENSE. First, vessel tracking experimentswere performed invitrowith a
dedicated vascular phantom to determine possible differences in the depiction of
cross-sectional areas of vessel segments. For the in vitro tests, an additional
3-dimensional proton density-weighted sequence was added for comparison rea-
sons. Second, 3 readers blinded to sequence details assessed qualitative (16 fea-
tures) and 2 readers assessed quantitative (contrast-to-noise ratio [CNR], contrast
ratio [CR], vessel sharpness, and full width at half maximum edge criterion mea-
surements) image quality based on images acquired from scanning 10 healthy vol-
unteers with all 5 TOF sequences. Scores from quantitative image quality analysis
were compared with Kruskal-Wallis, analysis of variance, or Welch's analysis of
variance, followed by Dunnett's or Dunnett's T3 post hoc tests. Scores from qual-
itative image quality analysis were compared with exact binomial tests, and the
level of interreader agreement was determined with Krippendorff's alpha.
Results: Concerning the in vitro tests, there were no significant differences be-
tween the 5 TOFs and the proton density-weighted sequence in measuring cross-
sectional areas of vessel segments (P = 0.904). As for the in vivo tests, the CS
3.5 exhibited equal qualitative image quality as the SENSE, whereas the 3 spiral-
TOFs outperformed the SENSE in several categories (P values from 0.002 to
0.031). Specifically, the spiral 0.8 and 0.6 sequences achieved significantly
higher scores in 12 categories. Interreader agreement ranged from poor (al-
pha = −0.013, visualization of internal carotid artery segment C7) to substantial
(alpha = 0.737, number of vessels visible, sagittal). As for the quantitative metrics,
the CS 3.5 and all 3 spiral-TOFs presented with significantly worse CNR than the
SENSE ([mean ± SD] SENSE 37.48 ± 7.13 vs CS 3.5 31.14 ± 5.97 vs spiral
19.77 ± 1.65 vs spiral 0.8 16.18 ± 2.14 vs spiral 0.6 10.37 ± 1.05). The CR values
did not differ significantly between the SENSE and the other TOFs except for the
spiral sequence that showed significantly improved CR (SENSE 0.53 ± 0.03 vs
spiral 0.56 ± 0.03). As for vessel sharpness, the SENSE was outperformed by
all spiral-TOFs (SENSE 0.37 ± 0.03 vs spiral 0.52 ± 0.07 vs spiral 0.8
0.53 ± 0.08 vs spiral 0.6 0.73 ± 0.09), whereas the CS 3.5 performed equally well
(SENSE 0.37 ± 0.03 vs CS 3.5 0.37 ± 0.03). Full width at half maximum values
did not differ significantly between any TOF.
Conclusions: Spiral-TOFs may deliver high-quality intracranial vessel imaging
thus matching the performance of conventional parallel imaging–accelerated
TOFs (such as the SENSE). Specifically, imaging can be performed at unprece-
dented scan times as short as 1:32 minutes per sequence (70.12% scan time re-
duction compared with SENSE). Optionally, spiral imaging may also be used
to increase spatial resolution while maintaining the scan time of a Cartesian-
based acquisition schema. The CNR was decreased in spiral-TOF images.
Key Words: spiral, sparse undersampling, compressed sensing,
magnetic resonance angiography, time of flight
(Invest Radiol 2019;00: 00–00)
T ime-of-flight (TOF) magnetic resonance angiography (MRA) is anoninvasive and contrast media–free MR technique that can be
used to image intracranial vessels. Time-of-flight MRA has been shown
to be an effective and reliable alternative to digital subtraction angiogra-
phy and has thus been widely adopted in clinical institutions for use in
patients with suspected intracranial vascular disorders such as stenoses
or aneurysms.1–7
Currently, parallel imaging (PI; ie, techniques such as sensitivity
encoding, SENSE)–accelerated TOF MRA sequences are considered
the criterion standard for intracranial vessel MR imaging.8–10 Paral-
lel imaging is a common k-space undersampling method that relies
on the reduction of the number of phase-encoding steps. The accel-
eration factor chosen for PI imaging, however, rarely exceeds 2 or 3,
and thus PI-accelerated TOFs are still quite time-consuming, thereby
rarely achieving scan times below 5 minutes.2 By combining TOFMRA
sequences with compressed sensing (CS) technology, a further reduction
of scan times is possible. Compressed sensing algorithms achieve higher
k-space undersampling by using the underlying sparsity in an appropriate
transform domain.1–7
Recent studies demonstrating the efficacy of CS-accelerated TOFs
have employed a range of sequences of which some even achieve scan
times of slightly above 2:30 minutes.1,2,6,7 Although this represents a con-
siderable time saving in comparison to conventional PI-accelerated TOFs, a
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further reduction of scan times considerably below 2 minutes with ac-
ceptable image quality seems improbable with the currently available
acceleration techniques.
However, spiral MR imaging using a non-Cartesian acquisition
technique may enable higher scan speeds, as the spiral traverses the
k-space more efficiently per given time than in Cartesian trajectories.11–15
Although the theoretical concept of spiral MR imaging has been described
a long time ago, it has only very recently become a potentially viable option
for intracranial vessel imaging with TOF MRA sequences.11–15
In this pilot study, we therefore report about the first time use of
spiral TOFMRA sequences (spiral-TOF) at 1.5 T for intracranial vessel
imaging. To this extent, 3 spiral-TOFs and a CS-accelerated TOF (named
CS 3.5) were tested in in vitro experiments with a dedicated intracranial
vascular phantom model followed by in vivo imaging in volunteers thus
highlighting the spiral-TOFs' and the CS 3.5's performance in compar-
ison to a conventional PI-accelerated TOF sequence (named SENSE)
utilizing qualitative and quantitative image quality metrics.
MATERIALS AND METHODS
This study was approved by the Cantonal Ethical Committee Zu-
rich, Zurich, Switzerland (BASEC Number 2018-01275) with written in-
formed consent from all volunteers.
Study Design
In this study, 3 spiral-TOFs and a CS-accelerated TOF (CS 3.5)
were evaluated and compared with a PI-accelerated TOF (SENSE, crite-
rion standard) sequence. In the in vitro experiments, the accuracy of the
sequences in displaying the cross-sectional area of vessels was assessed
with a vascular phantom model16,17 and a vessel tracking software. In
the in vivo part, the 5 sequences were scanned in 10 healthy volunteers
thus enabling an intraindividual comparison between the different TOFs.
Qualitative image quality was rated in a blinded fashion by 3 readers with
a 5-point Likert scale in comparison to the SENSE, and images were
quantitatively evaluated by means of contrast-to-noise ratio (CNR), con-
trast ratio (CR), vessel sharpness (VS), and full width at half maximum
edge criterion measurements by 2 readers.
MR Imaging
All images were acquired on a 1.5-T scanner (Ingenia; Philips
Healthcare, Best, the Netherlands) using a 16-channel head coil and
product software (R5.6). A sagittal 3-dimensional (3D) T1w turbo field
echo sequence (field of view, 240 240 cm2; matrix, 240 240; num-
ber of slices, 275; TR/TE/TI, 7.6/3.5/1000 milliseconds; flip angle, 8
degrees; scan duration, 3 minutes 50 seconds) was used for the planning
of the TOFs. The 5 sequences were acquired in identical orientation par-
allel to the splenium and genu of the corpus callosum (in case of the vol-
unteer scans). All TOFswere based on amultichunk (5 chunks) acquisition
and a TONE ramp of 17 degrees at the entry slice, 20 degrees at mid-slab,
and 23 degrees near the exiting slice. All TOFs used in this study rep-
resent 3D TOF MRA sequences.
Three sequences had an identical geometric resolution (voxel
size, 0.82  0.82  1.2 mm3): first, the SENSE sequence using the
SENSE PI technique (SENSE factor 2, scan duration, 5:08 minutes);
second, the CS 3.5 sequence using the compressed SENSE acceleration
techniquewith a variable density Poisson disk-sampling scheme followed
by iterative reconstruction (compressed SENSE factor, 3.5; scan duration,
3:06minutes)18–20; and third, a spiral-TOF (abbreviated spiral) based on a
stack of spirals with an in-plane spiral-out readout scheme (spiral inter-
leaves, 27; spiral acquisition window, 10 milliseconds; scan duration,
1:32minutes). In addition, 2 sequenceswith the same spiral-out readout
scheme but higher resolution were acquired—the isotropic spiral-TOF
0.8 (abbreviated spiral 0.8) (voxel size, 0.80  0.80 0.80 mm3; scan
duration, 2:12 minutes) and the isotropic spiral-TOF 0.6 (abbreviated
spiral 0.6) sequences (voxel size, 0.60 0.60  0.60 mm3; scan dura-
tion, 5:22 minutes). Details of the imaging parameters of all 5 TOFs are
given in Table 1, and a diagram of the spiral acquisition method is given
in Figure 1. The sequences' parameters were defined based on the
vendor's implementation. Specifically, the spiral sequence was pro-
vided (and recommended) as such by the vendor and represents a se-
quence that was optimized by the vendor in terms of performance in
the preclinical phase of development. As for the resolutions of the spiral
0.8 and spiral 0.6 sequences, we first chose an isotropic resolution that
was as close to the spiral, SENSE, and CS 3.5 sequences resolutions
(thus 0.8 mm3 for the spiral 0.8), and second, the highest possible
TABLE 1. Sequence Parameters of the 3D PDw and TOF MRA Sequences
3D PDw SENSE CS 3.5 Spiral Spiral 0.8 Spiral 0.6
Field of view, mm 200  200  90 200  200  90 200  200  90 200  200  90 200  200  90 200  200  92
Acq. voxel size, mm 0.5  0.5  0.5 0.82  0.82  1.2 0.82  0.82  1.2 0.82  0.82  1.2 0.82  0.82  0.82 0.60  0.60  0.60
Rec. voxel size, mm 0.5  0.5  0.5 0.39  0.39  0.6 0.39  0.39  0.6 0.39  0.39  0.6 0.39  0.39  0.41 0.39  0.39  0.30
No. slices 180 150 150 150 220 305
TR/TE, ms 1100/32 23/6.9 23/6.9 23/2.3 23/2.3 23/2.3
Flip angle, degree 90 20 20 20 20 20
SENSE factor NA 2 NA NA NA NA
C-SENSE factor NA NA 3.5 NA NA NA
Spiral acquisition
window/no. spiral interleaves
NA NA NA 10 ms/27 10 ms/27 10 ms/48
Saturation slab 0 1 1 1 1 1
Receiver bandwith 440.1 Hz/pixel 108 Hz/pixel 108 Hz/pixel 100 Hz/pixel 100 Hz/pixel 100 Hz/pixel
No. signal averages 1 1 1 1 1 1
Flow compensation No Yes Yes Yes Yes Yes
TONE ramp pulse NA Yes Yes Yes Yes Yes
No. chunks NA 5 5 5 5 5
Scan duration, min:s 13:09 05:08 03:06 01:32 02:12 05:22
3D indicates 3-dimensional; PDw, proton density-weighted; TOF, time-of-flight; MRA, magnetic resonance angiography.
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isotropic resolution that was the most comparable in scan time to the
SENSE's scan time (thus 0.6 mm3 for the spiral 0.6). Blurring due to
off-resonance was corrected during reconstruction based on a magnetic
field map acquired before the spiral scan.
In Vitro Study
In this part of the study, vessel tracking experiments (Fig. 2) were
performed with a dedicated vascular phantom model.16,17 The cross-
sectional area of segments of arteries were measured on the maximum
intensity projection (MIP) images of the 5 different TOFs and a 3D pro-
ton density-weighted (PDw) sequence by the help of a vessel tracking
tool called “advanced vessel analysis” AVA on IntelliSpace Portal ver-
sion 10 (Philips Healthcare, Best, the Netherlands). Cross-sectional area
values from the 6 sequences were then compared.
The 3D PDw sequence (isotropic resolution of 0.5 mm3, Table 1)
was added to the in vitro protocol, as it also enables vessel imaging but
relies on a different physical principle for image acquisition. Most impor-
tantly, however, PDw imaging has previously been described to enable a
very accurate depiction of vessels in an in vitro setting,21 thus making it a
good candidate for an additional comparison of cross-sectional areas.
To test this, a self-made model consisting of a plastic box filled
with 3 different water-loaded flexible tubeswith exactly known dimensions
FIGURE 1. Pulse sequence diagram of the spiral-TOF sequences. One in-plane spiral-out trajectory from the whole stack of spirals is shown.
FIGURE 2. In vitro vessel tracking experiments. A, Image depicts a representative example of a vessel tracking experiment performed on the vertebral
artery of the dedicated vascular phantommodel. The starting point was set at the lowest possible point on the image (which corresponded to 155mm
according to the software's internal reference position system) and 5 further points (thus 6 points in total) were then defined at certain distances away
fromwhich cross-sectional area measurements were to be taken (0, 25, 35, 45, 55, 75 [endpoint] mm away from the start point). Cross-sectional areas
were calculated based on the average value of themaximum andminimumdiameter as seen on (A) in the bottom right corner. B and C, Images show the
vascular phantom model. D, Image of the pump that generated a constant water flow through the models vasculature.
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(cross-sectional areas of the tubes: [1] 3.142 mm2, [2] 12.566 mm2, and
[3] 28.274 mm2) molded into solid agar was scanned with the 3D PDw
sequence. Time-of-flight imaging could not be performed with this
model as no pump (that could have generated water flow) could be at-
tached to the tubes.
Using the vessel tracking tool, the tubes were tracked on their
full length on the PDw images and their dimensions were measured.
We determined that the PDw sequence could accurately depict the tubes
cross-sectional areas as only small deviationswere observed (maximum
deviations for each tube: 3% for tube [3] and 5% for tubes [1, 2]). Thus
for the in vitro experiments, measurements from the 5 TOF sequences
were also compared with the values of the 3D PDw sequence.
As an alternative to the PDw sequence, images from a CT scan
could have also functioned as an interesting additional candidate for
comparison of measurements. However, this would have required mov-
ing the phantom between 2 different scanners, thus requiring realignment
of images later in the experiment (for selection of the points used for mea-
surements). Although the CT scan may have theoretically rendered an
even more accurate depiction of vessels than the PDw sequence, the re-
alignment process would probably have contributed to a considerable
loss of accuracy for.
In a second step, all further in vitro experiments were performed
with a dedicated vascular phantom model of intracranial vessels manu-
factured by Elastrat Sàrl, Geneva, Switzerland (model: H+N-R-A-002).16,17
Specifically, the model encompasses the circle of Willis with 2 large
posterior communicating arteries and 2 small P1 segments of the cere-
bral posterior artery as well as a large anterior communicating artery
(ACA) with a large A1 segment of the anterior cerebral artery on the
right side. In addition, an aneurysm is located at the junction of the right
A1 segment and the ACA. The phantom was placed into the MR scan-
ner, and a pump, generating a static rather than an oscillating water flow
through the vessels of the phantom, was attached.
The phantom was first scanned with the 3D PDw sequence
followed by the 5 other sequences (SENSE, CS 3.5, spiral, spiral 0.8, spi-
ral 0.6). During the acquisition of the 3D PDw sequence, the flow pump
was switched off, since this image contrast should not be disturbed by
flow effects. For the 5 TOF sequences, a constant flow of 7 mL/s at the
level of the internal carotid artery (ICA) was pumped through the vas-
cular phantom. The phantom was not moved in between scans thus
allowing for the acquisition of 6 geometrically identical image datasets.
Using the vessel tracking tool, the cross-sectional areas of the
vessels were then obtained. The tool requires the user to set a start
and end point on the vessel that is to be tracked. As a starting point,
we selected the lowest possible point on the vertebral artery that was
visible on the images. The end point, being 75 mm away from the start
point,was set on the P3 segment of the posterior cerebral artery shortly before
the end of thevesselwithin the phantom.Beginning at the start point, 6 points
at certain distances afar were defined (ie, 0, 25, 35, 45, 55, 75mmaway from
the start point) atwhichmeasurements of thevessels cross-sectional areawere
to be taken. These 6 points corresponded to 1 measurement on the ver-
tebral artery, 2 measurements on the basilar artery, and 1 measurement
each of the P1, P2, and P3 segments of the posterior cerebral artery.
A similar procedure was performed for the ICA. The start point
was chosen as the lowest possible point on the ICA. The end point was
selected 150 mm away from the start point thus being in the M4 seg-
ment of the middle cerebral artery. Seven points beginning from the
start point were then selected for cross-sectional area measurements,
at 0, 30, 60, 90, 120, and 150 (endpoint) mm away from the start point.
These 7 points corresponded to 1 measurement in the C1 and 1 mea-
surement in the C3 segments of the ICA and 1 measurement each in
the M1, M2, M3, and M4 segments of the middle cerebral artery.
As the phantom was not moved between acquisitions of the dif-
ferent sequences, this process enabled us to always select the exact same
points for measurements in all 6 sequences thus explaining the utility of
the in vitro tests. The placement of points was performed by a senior
neuroradiologist with 30 years of experience (S.S.) and was checked by a
second reader with 3 years of experience in medical imaging research (T.S.).
In Vivo Study
Ten healthy volunteers (mean age, 37 ± 14 years; age range,
20–60, 3 women) were recruited. Inclusion criteria for the subjects were
older than 18 years, no known cerebral vascular diseases or abnormal-
ities, and no contraindications for MR imaging examinations as deter-
mined on the clinically available questionnaire that had to be filled in
before the MR examination.
Qualitative Image Quality Analysis
For the qualitative image quality analysis, all volunteer images
were analyzed by 3 readers (S.S., board-certified neuroradiologist with
30 years of experience; Á.S., board-certified neuroradiologist with
7 years of experience; T.S., research assistant with 3 years of experience
in medical imaging). For statistical analysis, the scores from reader 1
(S.S.) were considered as the representative values due to reader 1 being
the most experienced.
All readers independently evaluated MIP and source images and
were thereby blinded to the volunteer details and imaging technique.1,6
All images were transferred to the IntelliSpace portal workstation and
displayed to the readers in a random order and with image annotations
switched off (blinded read out). First, the readers determined their over-
all subjective preference and their overall impression of the VS. Second,
they gave their overall impression of the number of vessels visible on
coronal and sagittal images. Third, the readers continued with rating
the visualization of the following anatomical vessel segments: middle
cerebral artery M1, M2–M3, M4 segments, ICAC7 segment, ICA hor-
izontal petrous segment, ICAvertical petrous segment, anterior cerebral
artery A1, A2–A3 segments, ACA, posterior communicating artery
(PcomA), and ophthalmic artery. Lastly, inhomogeneous intraluminal sig-
nal (ie, signal decreasewithin middle of vessel lumen) within the segments
ICAC7,M1, andA1was evaluated. The 4 sequences (CS 3.5, spiral, spiral
0.8, spiral 0.6) were always compared against the SENSE sequence (crite-
rion standard)6 using a 5-point Likert scale (1 = much worse, 2 = worse,
3 = similar, 4 = better, 5 = much better). After the rating process, the
readers were also questioned about the occurrence of specific artifacts
and about the rating process in general. Representative image examples
are shown in Figure 3, Figure 4, and Figure 5.
Quantitative Image Quality Analysis
Quantitative measurements were performed by 2 readers (M.W.
with 20 years of experience in medical imaging, L.VS. with 7 years of
experience in medical imaging) for each volunteer and each sequence,
and the average value of both readers was subsequently considered as
the representative value for statistical analysis.
Contrast-to-Noise Ratio
For both CNR andCR analysis, 2 circular regions of interest (ROIs)
were drawn on source images1 on the independent workstation IntelliSpace
Portal version 10 (Philips Healthcare, Best, the Netherlands). One ROI
(size 3.54 ± 0.09 mm2) was drawn on the basilar artery (ROIvessel) and a
second ROI (size 107.85 ± 7.45 mm2) within the brainstem on the same
slice location (ROIbrainstem). Regions of interest were copied from one
sequence to another to ensure equal ROI sizes between the sequences
from each volunteer. As shown in Figure 6, a sectionwas chosen, which
was at mid feet-head distance of the basilar artery (thus directly below
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FIGURE 3. Representative examples of source images and maximum intensity projections (MIPs) of the 5 TOF sequences. The decreased CNR of the 3
spiral-TOFs can be observed on the source images.
FIGURE 4. Representative examples of maximum intensity projections (MIPs) of the 5 TOF sequences from 6 volunteers.
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Contrast Ratio
Contrast ratio22 was calculated from the same ROIs as the ones
used for CNR using the following formula:
CR ¼
mean SIROIvesselð Þ−mean SIROIbrainstemð Þð Þ
mean SIROIvesselð Þ þ mean SIROIbrainstemð Þð Þ
Vessel Sharpness
For estimation of VS,23 a line profile perpendicular to the M1
segment of the right middle cerebral artery was generated using FIJI's20
“Line Profile” function (Fig. 7). To compare the different sequences,
signal intensities were normalized to the peak signal intensity along the
profile for each sequence. Then the slope of the regression line for the an-
terior vessel border (sloperise) and the posterior vessel border (slopefall)
was calculated with Excel's built-in “slope function.” The mean of
sloperise and the absolute value of slopefall was calculated to report a
quantitative number for VS.
Vessel sharpness ¼ mean sloperise þ abs slopefall
  
Full-Width at Half Maximum Edge Criterion
The FWHM edge criterion is a quantitative metric that allows for
a reliable and robust estimation of a vessel lumen's edge by defining the
boundary at 50% intensity level between maximum (lumen) and mini-
mum (tissue). A vessel lumen can therefore be detected with the full
width at half maximum criterion, and vessel parameters such as diame-
ter or cross-sectional area can then be derived accurately.24,25 To gener-
ate FWHM values, the line profile from the M1 segment of the right
middle cerebral artery computed with FIJI's “Line Profile” function
was used. The length (in millimeter) at the half maximum of the line
profile curve was measured thus revealing the FWHM value.
Statistical Analysis
Data were initially checked with Levene test for homogeneity of
variance, Q-Q plots, and Shapiro-Wilk test for normality of residuals.
To compare cross-sectional area measurements from the in vitro study,
the Kruskal-Wallis test was applied as residuals were not normally dis-
tributed. Values for CNR were log-transformed to achieve normality of
residuals. For log-transformed CNR, CR, VS, and FWHM measure-
ments, analysis of variance (ANOVA) or Welch's ANOVA (for unequal
variances) was performed to evaluate whether the means were different
between the 5 TOFs. In case of a significant result, post hoc tests (Dunnett's
post hoc test or Dunnett's T3 post hoc tests for unequal variances) were
performed. For qualitative image quality metrics, exact binomial tests
were performed to test the null hypothesis that the probability for better
results (ratings: 4/5) was equal to the probability for worse results (rat-
ings: 1/2) in comparison to the SENSE sequence. Krippendorff's alpha
was computed to evaluate the interreader agreement for qualitative im-
age quality ratings. The following scalewas used to indicate the level of
agreement: 0.0–0.20 = poor agreement, 0.21–0.40 = fair agreement,
0.41–0.60 = moderate agreement, 0.61–0.80 = substantial agreement,
and 0.81–1.00 = almost perfect agreement.26 A P value of less than 0.05
was considered significant. All analyses were performed in the R pro-
gramming language (version 3.3.3) (R Core Team, 2017). The package
“multcomp” (Hothorm, Bretz, Westfall, 2008) and “DTK” (Lau, 2013)
were used to run post hoc tests. The package “irr” (Gamer, Lemon, Fel-
lows, Singh, 2012) was used to compute Krippendorff's alpha.
RESULTS
In Vitro
A detailed overview is provided in Table 2. In summary, the
values for cross-sectional area measurements were not significantly dif-
ferent between the 6 sequences (P = 0.904). Furthermore, when only
comparing values from the 5 TOF sequences (thus not considering
the values from the 3D PDw sequence), values were also not signifi-
cantly different (P = 0.966).
In Vivo
Qualitative Image Quality Analysis
A detailed overview of scores is given in Table 3. In brief, the CS
3.5 performed equally well as the SENSE in every category. The spiral
sequence performed equally well as the SENSE except for the visuali-
zation of the M1 segment, where the spiral sequence performed signif-
icantly worse than the SENSE. However, the spiral sequence significantly
outperformed the SENSE in terms of VS, visualization of the ICA hori-
zontal petrous segment, and visualization of the A1 segment. The spiral
0.8 and spiral 0.6 sequences outperformed the SENSE in the categories
subjective preference, VS, number of vessels visible in both coronal
and sagittal fixed positions, visualization of the segments ICA horizon-
tal petrous, ICA vertical petrous, M2–M3, M4, A1, A2–A3, PcomA,
and ophthalmic artery. As for inhomogeneous intraluminal signal
FIGURE 5. Zoomed-in areas of maximum intensity projections (MIPs) of the TOF images from one volunteer. Note the improved vessel visibility and
sharpness seen on spiral-TOF images (dashed circles and white arrows in B). Furthermore, an improved visualization of the carotid siphon can be
appreciated on the spiral-TOF images (white arrows in A).
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within the segments ICAC7, M1, and A1, both sequences exhibited sig-
nificantly worse scores than the SENSE. Lastly, the readers noted that
they did not notice any specific artifacts.
Concerning the interreader agreement, poor to substantial agree-
ment was found both when considering all 3 readers and only the 2most
experienced readers. However, on average, interreader agreement was
better when only the 2most experienced readers were considered. In ad-
dition, upon questioning, the 3 readers noted that they felt that personal
preference played an important role in rating of images. For example,
some preferred the visualization of the ICA C7 segment on spiral-
TOF images, whereas others preferred the SENSE's or CS 3.5's visual-
ization of the segment. This is reflected in the low interreader agreement
in this category.
Quantitative Image Quality Analysis
Detailed results are provided in Table 4 and visualized
in Figure 8.
Contrast-to-Noise Ratio
For statistical analysis, the values for CNRwere log-transformed
to achieve normality of residuals. The ANOVA indicated that the means
were different (P < 0.001) between the 5 TOFs. Dunnett's post hoc tests
showed that the CS 3.5 and all 3 spiral sequences (spiral, spiral 0.8, spiral
0.6) were significantly different from the SENSE. Although the SENSE
sequence only slightly outperformed the CS 3.5 in terms of CNR, all 3
spiral sequences presented with considerably lower CNR values than
the SENSE. This can even be seen on the grainy and noisy appearing
source images of the spiral-TOFs (Fig. 3).
Contrast Ratio
The ANOVA indicated that the group means between the 5 se-
quences were different (P = 0.002). Dunnett's post hoc tests showed that
only the spiral sequence differed significantly from the SENSE. Specif-
ically, the spiral sequence slightly exceeded the SENSE's performance
in terms of CR.
Vessel Sharpness
Welch's ANOVA and Dunnett's T3 post hoc tests were per-
formed because of unequal variances. Welch's ANOVA indicated
that the group means of the 5 sequences were different (P < 0.001).
Dunnett's T3 post hoc tests showed that there was no significant differ-
ence between the CS 3.5 and the SENSE. However, the spiral, spiral
0.8, and spiral 0.6 sequences all significantly outperformed the sense
sequence in terms of VS.
FIGURE 6. Representative example of ROI placement on source images
(in this case stemming from the SENSE sequence) for contrast-to-noise
ratio (CNR) and contrast ratio (CR) measurements (A). Regions of interest
were always placed on a slice as defined by a line that was set directly
below the carotid siphon (B).
FIGURE 7. Representative example of a TOF source image (A) (in this case stemming from the SENSE sequence) used for quantitative image quality analysis.
Based on a line profile perpendicular to the M1 segment of the right middle cerebral artery, vessel sharpness and FWHM values were derived (B).
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Full Width at Half Maximum
Although the ANOVA indicated that the group means of the 5
sequences were different (P = 0.039), Dunnett's post hoc tests showed
that neither the CS 3.5 nor the 3 spiral sequences differed significantly
from the SENSE.
DISCUSSION
In this study, we presented data on the first-time use of spiral-
TOFs for intracranial vessel imaging at 1.5 T. We tested 5 TOF sequences,
of which 3 were spiral-TOFs, one was a CS-accelerated TOF (named
CS 3.5), and one was a PI-accelerated TOF (named SENSE). Most im-
portantly, we showed that spiral intracranial vessel imaging was fea-
sible in healthy volunteers as spiral-TOFs (spiral, spiral 0.8, spiral 0.6)
outperformed the SENSE in certain qualitative and quantitative image
quality metrics. Furthermore, spiral-TOFs may be of interest to clinical
institutions as scan times can be reduced considerably beyond what is
achievable with currently employed TOFs.
Spiral MR imaging has been described a long time ago11–15 and
has been applied in various settings and anatomies. Specifically, spiral
imaging has been used for coronary artery imaging, functional imaging,
pelvic imaging, black-blood imaging of peripheral vasculature, and
postcontrast brain imaging.11,15However, to the best of our knowledge,
the spiral acquisition technique has never been utilized in combination
with TOF MRA imaging and therein for intracranial vessel imaging.
Parallel imaging–accelerated TOFs such as the SENSE are con-
sidered the criterion standard for contrast-free intracranial vessel MR
imaging, yet recently, studies comparing CS-accelerated TOFs with
PI-accelerated TOFs suggest that CS-accelerated TOFs may be able
to replace PI-accelerated TOFs as image quality can be maintained
while reducing acquisition times.1–7
A recent study has shown that a CS-accelerated TOF achieved
comparable image quality as a conventional PI-accelerated TOF. In addition,
better delineation of vessel segments, fewer artifacts, and higher CRs were
observed when using the CS-accelerated sequence.7
A further study led by Lin et al reached a similar conclusion. In
their intraindividual comparison study, 49 patients with suspected
intracranial arterial diseases were prospectively scanned with both
PI- and CS-accelerated sequences. After rating by 3 radiologists, the
CS-accelerated sequencewas found to exhibit better image quality with
less blur, higher signal-to-noise ratio (SNR) and CNR, and comparable
image diagnostic performance of intracranial arteries in comparison
with the conventional TOF.1
Fushimi et al focused specifically for aneurysm imaging. Time-
of-flight imaging was performed in 20 patients with 26 aneurysms. Be-
sides rating the overall visualization, the aneurysm dimensions were
measured and compared between PI- and CS-accelerated sequences.
The authors found no differences between the 2 sequences both in terms
of image quality and dimensions of the aneurysms.2
Lastly, CS-accelerated TOFs were also found to be reliable alter-
natives to conventional PI-accelerated TOFs in the imaging ofmoyamoya
disease and for diagnosing intracranial arterial stenosis.4–6
Except for a slightly lower CNR observed in our CS 3.5 sequence,
we found no significant difference between our CS 3.5 and SENSE se-
quences. Thus, we largely confirm the findings of previously published
studies. In contrast to us, Lin et al observed higher CNR using their
PI-accelerated TOF. This discrepancy may be caused by slight differ-
ences in the denoising procedure of CS reconstruction.
TABLE 2. Quantitative Data From In Vitro Vessel Tracking Experiments
3D PDw SENSE CS 3.5 Spiral Spiral 0.8 Spiral 0.6
Area, median [IQR], mm2 13 [6.5, 22.8] 11.6 [6.4, 15.3] 11.3 [5.7, 14.1] 10.5 [4.4, 14] 10.4 [5.5, 14.9] 10.8 [5.5, 14.1]
Median difference to 3D PDw, mm2 −0.9 −1.6 −2.0 −1.1 −2.0
Median difference to SENSE, mm2 −0.3 −1.1 −0.5 −0.8
3D indicates 3-dimensional; PDw, proton density-weighted; IQR, interquartile range.

















CS 3.5 3 [3, 3] 3 [3, 3] 3 [3, 3] 3 [3, 3] 3 [3, 3] 3 [3, 3] 3 [3, 3] 3 [3, 3]
Spiral 3 [3, 3] 4 [3.25, 4]; 0.016+ 3 [3, 3.75] 3 [3, 3] 2 [2, 3]; 0.031− 3 [3, 4] 3 [3, 3] 2.5 [2, 3]
Spiral 0.8 4 [3.25, 4]; 0.016+ 4 [4, 4]; 0.002+ 4 [4, 4]; 0.021+ 4 [4, 4]; 0.002+ 3.5 [3, 4] 4 [4, 4]; 0.004+ 4 [4, 4]; 0.008+ 3 [2, 3]









0.543 0.737 0.788 0.699 0.201 0.347 0.781 0.0268
Scores are given asmedian [interquartile range];P value. Only significantP values are shown, and significantly better scores in comparison to the SENSE sequence are
indicated with a superscript “plus” (+) after the P value, while significantly worse scores in comparison to the SENSE sequence are indicated with a superscript “minus”
(−) after the P value.
ICA indicates internal carotid artery; anterior ACA, communicating artery; PcomA, posterior communicating artery.
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Although generally the spiral-TOFs in this study outperformed
our SENSE, considerably lower CNR was found in all 3 spiral se-
quences. Contrast-to-noise ratio decreased with increasing resolution
of the spiral sequences, and this could even be seen on the source im-
ages that appeared noisy—signal-to-noise ratio scales with total voxel
volume and the square root of the acquisition time (tacq). The voxel vol-
ume equates to the product of slice thickness, the voxel size (x), and the
voxel size (y). Contrast-to-noise ratio reflects the difference in SNR be-
tween 2 tissue types (a, b). Contrast-to-noise ratio depends on the over-
all SNR and can be expressed as: CNR = SNRa − SNRb. The voxel
volume of the spiral sequence was identical to the voxel volume of
the SENSE and CS 3.5 sequences but exhibited a shorter tacq. There-
fore, a lower SNR/CNR can be expected. The voxel volume of the spi-
ral 0.8 and spiral 0.6 sequences was smaller than the voxel volume of
the SENSE and CS 3.5 sequences. Thus, the decrease in CNR in those
2 sequences is mainly caused by the lower voxel volume.
Yet given the fact that MIPs are often given preference over
source images by radiologists to assess intracranial vessel images, this
possible drawback of a lower CNR has to be further studied in the clin-
ical setting. The qualitative image quality rating performed mainly on
MIPs demonstrated that all spiral-TOFs were similar with our SENSE,
whereby the spiral 0.8 and spiral 0.6 sequences even clearly exceeded
the SENSEs performance in several categories. However, considerable
variability in scores was observed for the qualitative image quality rating,
which is reflected in the interreader agreement values. The interreader
agreement was better when only the 2 most experienced readers were
considered rather than all 3 readers, which may reveal that the experience
of raters influenced the scores. Thus for statistical analysis, the values of
themost experienced reader served as the representative values. However,
upon questioning of the 3 readers, each noted that they felt that personal
preference played an important role in rating of images, and this may
have been one of the main factors determining the rating scores.
Concerning the other quantitative metrics one spiral-TOF (spiral)
outperformed the SENSE sequence, whereas 2 spiral-TOFs (spiral 0.8 and
spiral 0.6) performed equally well in terms of CR. Moreover, all 3 spiral-
TOFs clearly demonstrated superior VS in comparison to the SENSE. Es-
pecially, the spiral 0.8 and spiral 0.6 sequences revealed greatly improved
VS, which may also be owing to the higher resolution of these TOFs.
As for the data gathered from the in vitro tests, no statistical dif-
ference between the values of the cross-sectional area measurements of
any TOF sequence and the 3D PDw sequence were found. This indi-
cates that the spiral-TOFs and CS 3.5 allow for the accurate depiction
of intracranial vessels dimensions in comparison to the SENSE and
3D PDw sequence. This is of substantial clinical importance, namely,
when diagnosing the degree of occlusion in arterial stenosis and also
for imaging and evaluating aneurysms. The fact that the FWHM values
(derived from in vivo imaging rather than in vitro) also did not differ sig-
nificantly between any TOF sequence further corroborates this finding.
Ultimately, the time savings associated with spiral-TOF imaging
must be strongly considered. The spiral-TOF (spiral) with equivalent
resolution as the SENSE and CS 3.5 clocked in at 1:32 minutes in con-
trast to 5:08 and 3:06 images for the other sequences, respectively, thus
representing a reduction of 70.12% and 50.54% in scan times. Alterna-
tively, depending on the needs of the patient and radiologist, spiral-TOF
imaging can also be performed at higher resolutionswithout prolonging
scan times. The spiral 0.8 sequence with an isotropic resolution of
0.8 mm3 lasted 2:12 minutes thus rendering a scan time reduction of
57.14% compared with the SENSE and a reduction of 29.03% com-
pared with the CS 3.5. As for the spiral 0.6 sequence with an isotropic
resolution of 0.6 mm3, its scan time (5:22 minutes) is largely compara-
ble to that of our SENSE yet displays a notably higher resolution.
Hence the question remains, “Which spiral-TOF sequence renders
the best performance?”Our data suggest that the spiral 0.8 sequence ex-
hibits an optimal scan time-quality ratio for normal arteries. This se-
quence achieves premium intracranial vessel imaging at slightly over
2 minutes while delivering significantly better image quality than the
SENSE, CS 3.5, and spiral-TOF. Furthermore, except for VS, the se-
quence nearly reaches the performance of the much slower spiral 0.6 se-
quence therein suggesting that the spiral 0.8 is the overall more suitable
candidate for future clinical imaging. However, one should also strongly
emphasize the impressive performance of the spiral sequence. With its
scan time of 1:32 minutes, this TOF truly deserves to be appraised as ul-
trafast, and considering the fact that the sequence mostly performed as
well or even better than our SENSE and CS 3.5, it may be a tempting fu-
ture candidate for clinical institutions with a very large patient turnover.
For the future, a combination of compressed sensing27–33 and PI
technology together with spiral acquisition may be very interesting as the
advantages of either methods can be combined and scan times may be re-
duced even further. However, the feasibility of such a combination would



















3 [3, 3] 3 [3, 3] 3 [3, 3] 3 [3, 3] 3 [3, 3] 3 [3, 3] 3 [3, 3] 3 [3, 3]
4 [3, 4]; 0.031+ 3 [3, 3.75] 4 [3, 4]; 0.031+ 3 [3, 4] 3 [3, 3.5] 3 [3, 3.75] 4 [3, 4] 2.5 [2, 3]
4 [4, 4]; 0.004+ 4 [3, 4]; 0.031+ 4 [3.25, 4]; 0.016+ 4 [4, 4]; 0.004+ 3 [3, 4] 4 [4, 4]; 0.008+ 4 [4, 4]; 0.021+ 2 [2, 2.75]; 0.016−
4 [4, 5]; 0.002+ 4.5 [4, 5]; 0.002+ 4 [3.25, 4]; 0.016+ 4 [4, 4.75]; 0.004+ 3 [3, 3.5] 4 [4, 4]; 0.004+ 4 [4, 4]; 0.002+ 2 [2, 2]; 0.039−
0.661 0.711 0.413 0.492 0.253 0.512 0.624 0.212
0.657 0.691 0.552 0.719 0.323 0.589 0.724 −0.112
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Lastly our study has some limitations. First, the sample size is fairly
small, although in the typical range for pilot studies evaluating and compar-
ing the feasibility and quality of novel sequences.34–40 Second, the vascular
phantom was operated with a pump that generated constant rather than
oscillating water flow. This may affect the generalizability of our in
vitro results since blood flow in vivo is pulsatile. Especially, one might
hypothesize that the lower CNR encountered in the spiral-TOFs may
become a problem in patients presenting with stenotic or post stenotic
arterial areas with low blood flow. Thus, a future study assessing the
clinical feasibility of spiral-TOF imaging is of great interest. Third,
for comparison reasons, we used a 3D PDw sequence in the in vitro ex-
periments rather than the true dimensions of the phantoms vessels'
(which were not known). Lastly, it should be acknowledged that there
are many formulas to determine CNR and CR1; therefore, results may
differ when applying different formulas.
To conclude, we provide data on the performance of 3 spiral-TOFs
and a CS-accelerated TOF (named CS 3.5) in comparison to a conven-
tional PI-accelerated TOF (named SENSE) and show that spiral-TOFs
deliver high-quality intracranial vessel imaging at unprecedented scan
times below 2 minutes. Future clinical studies assessing the diagnostic
TABLE 4. Data From the Quantitative Image Quality Analysis Is Presented
SENSE CS 3.5 Spiral Spiral 0.8 Spiral 0.6
Mean ± SD Mean ± SD (95% CI) Mean ± SD (95% CI) Mean ± SD (95% CI) Mean ± SD (95% CI)
CNR 37.48 ± 7.13 31.14 ± 5.97 (0.708, 0.977) 19.77 ± 1.65 (0.455, 0.628) 16.18 ± 2.14 (0.37, 0.511) 10.37 ± 1.05 (0.238, 0.329)
CR 0.53 ± 0.03 0.51 ± 0.03 (−0.042, 0.016) 0.56 ± 0.03 (0.005, 0.064) 0.55 ± 0.02 (−0.01, 0.049) 0.54 ± 0.02 (−0.017, 0.042)
Vessel sharpness 0.37 ± 0.03 0.37 ± 0.03 (−0.064, 0.056) 0.52 ± 0.07 (0.044, 0.259) 0.53 ± 0.08 (0.047, 0.273) 0.73 ± 0.09 (0.231, 0.478)
FWHM 2.4 ± 0.2 2.49 ± 0.25 (−0.307, 0.482) 2.09 ± 0.27 (−0.704, 0.085) 2.14 ± 0.3 (−0.652, 0.137) 2.11 ± 0.31 (−0.679, 0.111)
The 95%CIs fromDunnett's orDunnett's T3 post hoc tests are shown. The CIs give an estimate for the difference inmeans between the values of the 2 sequences being
compared. Positive lower confidence limits indicate higher values for tested TOF comparedwith SENSE; negative upper confidence limits indicate lower values for tested
TOF compared with SENSE. In the case of CNR, where valueswere log-transformed for ANOVA, the CI reveals bywhich factor the values from the 4 sequences (CS 3.5,
spiral, spiral 0.8, spiral 0.6) differ from the values from the SENSE sequence. All upper confidence limits are below 1, thus indicating that all tested TOFs have lower
values compared with SENSE.
CI indicates confidence interval; CNR, contrast-to-noise ratio; CR, contrast ratio; FWHM, full width at half maximum.
FIGURE 8. Boxplots depicting data from quantitative image quality analysis (in vitro and in vivo). The line in the box shows the median, the lower, and
upper hinges correspond to the first and third quartiles. The upper/lower whisker extends from the hinge to the largest/smallest value no further than
1.5  IQR from the hinge.
Sartoretti et al Investigative Radiology • Volume 00, Number 00, Month 2019
10 www.investigativeradiology.com © 2019 Wolters Kluwer Health, Inc. All rights reserved.
                                            Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.                                               
                                 This paper can be cited using the date of access and the unique DOI number which can be found in the footnotes.
accuracy of spiral-TOFs are warranted. Furthermore, an investigation
into the use of spiral-TOFs at higher field strengths than 1.5 Twould
also be of clinical interest.
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